EMJ GOLD Podcast: Weekly Pharma Insights EMJ

The GOLD podcast is back and better than ever! Tune in as Isabel and Jade unveil GOLD's new brand identity 'EMJ GOLD' and enter Season 7 with new energy, new insights and on camera for the first time!
But who is the season's first guest? Meet Mercedes Diz, Chief Marketing Officer, Almirall, who spoke to Jade at the Reuters Pharma 2024 event in Barcelona earlier this year. In the interview, Jade asks Mercedes about Almirall's move from respiratory health to dermatology, pushing your limits to achieve your goals and how the industry can work to go beyond the surface to support patients with dermatological concerns.
A little more on GOLD’s guest… Mercedes Diz has over 20 years' experience in the pharmaceutical industry, having graduated with a degree in Biochemistry and Molecular Biology from the Autonomous University of Madrid. She has worked in a number of different pharmaceutical companies, from J&J to Pfizer, and is also a keen member of the Healthcare Businesswomen's Association. At Almirall, she leads portfolio strategy and commercial innovation for global brands, new products and digital and cultural transformation.

Join Isabel and Jade for this special episode of the GOLD podcast as three of last year's guests share their predictions for the pharmaceutical industry in 2024. The panel includes Matt Lewis from Inizio, Rick Hollis from Ipsen and Claudia Martinez from the Access to Medicine Foundation, all of whom share their predictions in their areas of expertise.

But that's not all. The GOLD hosts also reminisce about the team's 2023 predictions podcast to see if these guests could really see the future.

The Season 6 finale of the GOLD podcast has landed! Tune in to hear Isabel and Jade present a discussion with Kinnari Patel, President and Chief Operating Officer, Rocket Pharmaceuticals. 
In this episode, Kinnari shares her thoughts on how the industry can engage the next generation of scientific leaders to propel itself into the future. Tune in to find out what might be stopping the younger generation from pursuing a career in pharma and how the industry can work to change their minds, the benefits of a more diverse workforce, the future of drug development and more.
If you’re interested in learning more about the topic areas discussed in this episode, check out the following content: 
Mastering medical affairs

Taking women to the top of pharma

Do happy employees equal better innovation?

Last week's podcast: A patient's right to thrive, not just survive

Tune in to the latest episode of the GOLD podcast which sees Isabel sit down for a chat with Wendy Bartie, Senior Vice President and General Manager, US Hematology and Cell Therapy, Bristol Myers Squibb.
In the episode, Wendy discusses her passion for developing life-saving cancer drugs with less toxic side effects. Learn about how far the industry has come, while being guided through the ways in which the sector could still evolve for the benefit of patients.
If you’re interested in learning more about the topic areas discussed in this episode, check out the following content:
Going for gold in gynaecological cancers Mental health matters in pharma's approach to care Last week's podcast: What motivates and challenges GOLD's guests?

For each episode of Season 6, the GOLD team has asked its podcast guests to reflect on the same question: what gets you up in the morning, and what keeps you up at night?

 
As Season 6 nears its close, Isabel brings you a curated selection of insights from the leaders we have heard from so far. Tune in to find out what motivates these pharma aficionados and what they see as the key challenges in the industry today.

 
If you’re interested in learning more about the topic areas discussed in this episode, check out the following content: 

GOLD's latest roundtable: Was it worth the risk?
Last week's episode: Meet GOLD's latest Catalyst - Roche’s Dr Peter Ahnesorg

"}}},"VERSION":"9.14.7"}"> Tune in for a sneak peek of GOLD's latest Catalyst interview with Dr Peter Ahnesorg, Global Hematology Franchise Head, Roche.

 

In this exclusive teaser of the full interview, Peter talks about why he left research for industry, Roche's commitment to ensuring equitable access to its medicines and what he believes are the qualities of a good leader today.
 
If you’re interested in learning more about the topic areas discussed in this episode, check out the following content:

Podcast: Changing the tide on health inequities
Podcast: Do happy employees equal better innovation?
Last week’s podcast: A high-speed chase for oncology innovation